Trend Report

Trend Report: DE&I in Clinical Research: Where we are Today 

Recent FDA draft guidance and FDORA legislation have highlighted the urgency of improving representation of diverse populations in clinical trials.

While addressing this critical need is imperative, it can be difficult to pinpoint where the industry currently stands.

To learn more, Advarra and Acclinate surveyed the clinical research community on their DE&I in Spring 2023.

This report outlines key findings from that survey, including:
  • Prevalence of diversity plan submissions since FDA’s 2022 guidance
  • Organizational definitions of DE&I from sites, sponsors, and CROs
  • How the community is budgeting for and utilizing efforts to increase trial diversity
  • Impact of efforts to increase trial diversity

Download the report to find out what’s been done so far, and where we have room to grow.

Who Should Watch?

CEU Credits

Certificate of Attendance

Time: 1 p.m. ET, 12 p.m. CT, 10 a.m. PT
Duration: 1 hour

Download Now